| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.043 | 0.8 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.8 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |